Last checked at 13 Sep 2017 07:00
13 September 2017
Futura Medical plc
("Futura" or "the Company")
Directors' / PDMR Dealing and Grant of Options
Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, announces that on 12 September 2017 it granted options over a total of 1,440,000 ordinary shares of 0.2p each in the Company ("Ordinary Shares") to employees and Directors, of which 1,100,000 options were granted to Directors and PDMRs as detailed below.
Director | Number of options granted | Exercise price | Exercise period | Total number of options held following notification | Total number of Ordinary Shares held |
|
|
|
|
|
|
J H Barder | 250,000 | 30.5p | 1 Oct 2019 - 30 Sep 2024 | 1,750,000 | 1,528,830 |
|
|
|
|
|
|
D A Martin | 200,000 | 30.5p | 1 Oct 2019 - 30 Sep 2024 | 1,060,000 | 280,000 |
|
|
|
|
|
|
K W James | 200,000 | 30.5p | 1 Oct 2019 - 30 Sep 2024 | 400,000 | 13,787
|
PDMR | Number of options granted | Exercise price | Exercise period | Total number of options held following notification | Total number of Ordinary Shares held |
|
|
|
|
|
|
T Holland | 150,000 | 30.5p | 1 Oct 2019 - 30 Sep 2024 | 917,500 | - |
|
|
|
|
|
|
I Armstrong | 150,000 | 30.5p | 1 Oct 2019 - 30 Sep 2024 | 550,000 | - |
|
|
|
|
|
|
R Hawken | 150,000 | 30.5p | 1 Oct 2019 - 30 Sep 2024 | 150,000 | - |
|
|
|
|
|
|
The 650,000 options granted to: J Barder, D Martin and T Holland were granted under the Futura Medical plc Unapproved Share Option Scheme.
The 450,000 options granted to: K James, I Armstrong and R Hawken and the 340,000 options granted to other employees were granted under the Futura Medical plc Enterprise Management Incentive Scheme.
The main vesting condition of the options is that the Director/PDMR/employee remains employed with the Company as at the date of exercise.
For any further information please contact:
Futura Medical plc |
|
James Barder, Chief Executive | Tel: +44 (0)1483 685 670 |
mail to: james.barder@futuramedical.com | www.futuramedical.com |
|
|
Nominated Adviser: |
|
N+1 Singer Aubrey Powell / Liz Yong | Tel:+44 (0)20 7496 3000 |
For media enquiries please contact: |
|
|
|
Buchanan |
|
Mark Court / Sophie Cowles / Stephanie Watson | Tel: +44 (0)20 7466 5000 |
Notes to Editors
Futura Medical plc
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.
www.futuramedical.com
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| James Barder | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| Director | ||||
b)
| Initial notification /Amendment
| Initial notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| Futura Medical plc | ||||
b)
| LEI
| 21380053QLT46UNV2303 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument
Identification code
|
Ordinary shares of 0.2p each
GB0033278473 | ||||
b)
| Nature of the transactions
| Issue of options over Ordinary Shares
| ||||
c)
| Prices and volumes
|
| ||||
d)
| Aggregated information
- Aggregated volume
- Price
|
Not applicable
| ||||
e)
| Date of the transactions
| 12 September 2017 | ||||
f)
| Place of the transactions
| Outside a trading venue
| ||||
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| Derek Martin | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| Director | ||||
b)
| Initial notification /Amendment
| Initial notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| Futura Medical plc | ||||
b)
| LEI
| 21380053QLT46UNV2303 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument
Identification code
|
Ordinary shares of 0.2p each
GB0033278473 | ||||
b)
| Nature of the transactions
| Issue of options over Ordinary Shares
| ||||
c)
| Prices and volumes
|
| ||||
d)
| Aggregated information
- Aggregated volume
- Price
|
Not applicable
| ||||
e)
| Date of the transactions
| 12 September 2017 | ||||
f)
| Place of the transactions
| Outside a trading venue
| ||||
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| Ken James | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| Director | ||||
b)
| Initial notification /Amendment
| Initial notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| Futura Medical plc | ||||
b)
| LEI
| 21380053QLT46UNV2303 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument
Identification code
|
Ordinary shares of 0.2p each
GB0033278473 | ||||
b)
| Nature of the transactions
| Issue of options over Ordinary Shares
| ||||
c)
| Prices and volumes
|
| ||||
d)
| Aggregated information
- Aggregated volume
- Price
|
Not applicable
| ||||
e)
| Date of the transactions
| 12 September 2017 | ||||
f)
| Place of the transactions
| Outside a trading venue
| ||||
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| Tim Holland | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| PDMR | ||||
b)
| Initial notification /Amendment
| Initial notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| Futura Medical plc | ||||
b)
| LEI
| 21380053QLT46UNV2303 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument
Identification code
|
Ordinary shares of 0.2p each
GB0033278473 | ||||
b)
| Nature of the transactions
| Issue of options over Ordinary Shares
| ||||
c)
| Prices and volumes
|
| ||||
d)
| Aggregated information
- Aggregated volume
- Price
|
Not applicable
| ||||
e)
| Date of the transactions
| 12 September 2017 | ||||
f)
| Place of the transactions
| Outside a trading venue
| ||||
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| Ian Armstrong | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| PDMR | ||||
b)
| Initial notification /Amendment
| Initial notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| Futura Medical plc | ||||
b)
| LEI
| 21380053QLT46UNV2303 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument
Identification code
|
Ordinary shares of 0.2p each
GB0033278473 | ||||
b)
| Nature of the transactions
| Issue of options over Ordinary Shares
| ||||
c)
| Prices and volumes
|
| ||||
d)
| Aggregated information
- Aggregated volume
- Price
|
Not applicable
| ||||
e)
| Date of the transactions
| 12 September 2017 | ||||
f)
| Place of the transactions
| Outside a trading venue
| ||||
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| Rachael Hawken | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| PDMR | ||||
b)
| Initial notification /Amendment
| Initial notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| Futura Medical plc | ||||
b)
| LEI
| 21380053QLT46UNV2303 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument
Identification code
|
Ordinary shares of 0.2p each
GB0033278473 | ||||
b)
| Nature of the transactions
| Issue of options over Ordinary Shares
| ||||
c)
| Prices and volumes
|
| ||||
d)
| Aggregated information
- Aggregated volume
- Price
|
Not applicable
| ||||
e)
| Date of the transactions
| 12 September 2017 | ||||
f)
| Place of the transactions
| Outside a trading venue
| ||||